Pulmonary surfactant is a complex lipid-protein mixture that lowers the surface tension at the air-fluid interface in the lung. It consists of about 90% lipid and 5-10% surfactant-specific protein.
Structure and localization of SP-A
The primary structure of SP-A has been determined for several species including the human protein [3, 41 and is highly conserved. SP-A is a large complex molecule assembled from 18 polypeptide chains [S, 61 (Figure 1) . The primary translation product of human SP-A is 248 amino acids long and has distinct structural domains. The N-terminal part of the primary translation product is a signal peptide of 20 amino acids. Secreted SP-A has an N-terminal end of seven amino acids, containing a Abbreviations used: CKL), carbohydrate recognition domain; LPS, lipopolysaccharide; SP, surfactant protein.
cysteine residue that forms an intermolecular disulphide bond with another polypeptide chain of SP-A. The short N-terminal domain is flanked by a collagen domain that is characterized by 24 repeating triplets with the sequence Gly-Xaa-Yaa (Xaa is any amino acid and Yaa is hydroxyproline in 13 of the 24 triplets). The collagen triple helix unfolds when the temperature is raised. Human and canine SP-A have a midpoint transition temperature of 52.3f 1.7"C and 51.1 f 1.5"C respectively [6] . The sequence of repeating triplets is interrupted between the 13th and 14th repeat by the sequence Pro-Cys-Pro-Pro. Rotary shadowing electron microscopy of SP-A suggests that the six collagen triple helices of the molecule form a bundle of about 10 nm in length and about 4.5 nm in diameter along the first 13 triplets [ S ] . The break of the collagenlike sequence introduces a flexible kink in the collagen rods in such a way that beyond the 13th triplet the six individual triple helices fan out radially from the tightly associated stem (Figure 1) . A similar funnel-shaped structure has been described for complement factor C l q [7] . Both noncovalent and covalent interactions beween the helices provide stability to the stem. If the collagen-like domain is modelled as a 7 / 2 helical net, it becomes apparent that the hydrophobic and charged residues are clustered [6] . This charge distribution may help stabilize the oligomeric structure of SP-A. The collagen-like domain is linked to the globular C-terminal carbohydrate recognition domain (CRI)) by a stretch of amino acids, the 'neck-region'.
The A second physiological function of SP-A may be the regulation of surfactant homeostasis [22] . This putative function of SP-A has been suggested because the protein modulates uptake and secretion of phospholipids by isolated alveolar type I1 cells in vitro. However, in a recent study it was demonstrated by several techniques that SP-A does not enhance the gross rate of lipid endocytosis by type I1 cells [23] . Instead, SP-A only increases lipid uptake by the few type I1 cells that are in the immediate vicinity of SP-A liposome complexes. Thus, SP-A may not stimulate lipid uptake by type I1 cells by receptor-mediated endocytosis but may induce a local concentration-dependent uptake. SP-A has also been shown to inhibit secretion of phosphatidylcholines by type I1 cells that were labelled overnight with labelled choline (reviewed in [22] ). These in vitro studies suggest that SP-A may play a role in regulating alveolar pool size, by balancing surfactant release and clearance.
When its carbohydrate-binding properties were described it was recognized that SP-A may play a role in the pulmonary defence system [ 151. It was proposed that SP-A recognizes polysaccharides on the bacterial surface and initiates coating and phagocytosis of bacteria by alveolar macrophages. Since then, many results have indicated that SP-A may play an important role in the innate first-line defence mechanisms of the lung:
Binding to alveolar macrophages
Binding and receptor-mediated endocytosis of SP-A to rat alveolar macrophages [24] was reported to occur via its CRD. Other investigators came to the conclusion that SP-A binds alveolar macrophages via its collagen domain because both C l q and soluble collagen compete for the binding of SP-A to macrophages [ 251.
Effects on phagocytic functions
SP-A enhances phagocytosis of pathogens by alveolar macrophages. Van Iwaarden and coworkers demonstrated that SP-A from human alveolar proteinosis patients stimulates phagocytosis of radiolabelled, serum-opsonized, Staphylococcus aureus by rat alveolar macrophages in a surface phagocytosis assay [26] . In line with these observations it was reported that phagocytosis of complement and IgG coated erythrocytes is enhanced if macrophages are cultured on SP-A-coated plates [27] . These seminal studies indicated that SP-A may facilitate complement-and immunoglobulinmediated phagocytosis by alveolar macrophages. Recently SP-A-enhanced phagocytosis of nonopsonized bacteria by alveolar macrophages was also reported [28] . Human SP-A stimulates serumindependent phagocytosis of Eschm'h coli, Pseudomonas aeruginosa and Staphylococcus aureus by rat alveolar macrophages, depending on the growth phase of the bacteria. SP-A binds Staph. aureus and Streptococcus pneumoniae (type 25) in a calciumdependent manner and induces association of SP-A has also been reported to act as an opsonin in the phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages [31] . The opsonic capacity of SP-A was found to be twice as potent as that of serum. C l q could not substitute for this activity of SP-A. SP-A binds herpes simplex Human SP-A, purified from the lavage of alveolar proteinosis patients, enhances the lucigenindependent chemiluminescence response by rat alveolar macrophages [26] . In addition, the chemiluminescence response induced by rat surfactant can be abolished by antibodies against SP-A. These observations indicate that SP-A may also induce killing of microorganisms. The effect of SP-A is depressed by lipids. The SP-A-induced stimulation of superoxide radical production is not observed with peritoneal macrophages, polymorphonuclear leukocytes or monocytes [26] . SP-A itself is very susceptible to oxidation [ 341. Oxidized SP-A was not able to stimulate alveolar macrophages and act as an opsonin of viruses [35] .
Lipopoiysaccharide (LPS) scavenging
SP-A binds LPS (endotoxin) from Gram negative bacteria, and prevents binding to granulocytes and activation of these cells [36] . Recent work from our laboratory indicates that SP-A binds the Lipid A region of LPS, the region implicated in the pathogenesis of septic shock. Interestingly, SP-D also binds LPS but to the core region and not to the core-oligosaccharide-deficient Re chains or Lipid A. It can be speculated that SP-A and SP-D act in concert to scavenge free endotoxin.
Macrophage chemotaxis
Another possible function of SP-A was suggested recently by Wright and Youmans [37] . These investigators observed that SP-A (human, rat) stimulates rat alveolar macrophage chemotaxis. SP-A is a multifunctional protein. It has several functions in surfactant metabolism. In addition SP-A has many functions in the first line defence against inhaled pathogens. Although there are indications that SP-A levels change in toxic and diseased states [38] , it should be emphasized that most of the described functions are properties of SP-A in vitro. All these putative functions await experimental verification in vivo. It will be interesting to investigate regulation and site of SP-A expression under conditions of altered surfactant metabolism and in infection models in vivo. secretory granules of Clara cells, which were heavily labelled for SP-D, also contain SP-A. Interestingly, SP-A was distributed throughout the granule contents, whereas SP-D was confined to the periphery of the granule. The largest numbers of SP-D immunoreactive cells were observed in the distal membranous bronchioles. Scattered immunoreactive cells were found in the largest noncartilagenous airways but no labelling was observed in the major bronchi or trachea [47] . SP-A is focally expressed in airway cells [9] . In situ hybridization studies of SP-D mRNA are required to assess whether SP-D is also focally expressed in airway cells. Production of both SP-A and SP-D in bronchi would indicate that these proteins may also be important in the host defence in the airways and not only in bronchioli and alveoli.
Properties of SP-D
SP-D is not a real surfactant protein in the true sense since 90-95% of the protein was present in 48 000 g supernatants of lavages from normal rats. Until now there have not been many indications that the protein has an important function in surfactant homeostasis. Persson and coworkers examined the carbohydrate binding properties of rat . These studies indicated that SP-D has a considerable specificity for a-i)-glucosyl sugars. SP-D binding to maltosyl-BSA was most effectively completed with maltose, maltotriose, isomaltose and glucose [48] . The shape of SP-D is ideal for agglutination reactions. The molecule consists of four globular carbohydrate binding heads each connected to 46 nm long rods, which are associated via the free end. Thus, the molecule spans a long distance of 92nm, a feature that may be important for the agglutination of microorganisms.
Functions of SP-D
Although termed surfactant protein D, it is not immediately clear how this protein would play a role in surfactant homeostasis. There are indications that SP-D is involved in the first line defence against inhaled pathogens rather than in surfactant metabolism. The first indication is in its structure; SP-D is a member of the collectins, a group of proteins that play a role in the immediate response to infec- These investigators showed that rat SP-D enhances the production of oxygen radicals by rat alveolar macrophages but not by peritoneal macrophages SP-D agglutinates Gram negative bacteria and activates alveolar macrophages. Therefore it may enhance binding, uptake and killing of bacteria by alveolar macrophages. In addition, agglutinated bacteria may be cleared more rapidly from the lung via mucociliary transport. Another exciting function of SP-D (and SP-A) may be to scavenge free LPS (endotoxin). This would prevent LPS from binding to granulocytes and would consequently protect against septic shock. All these putative functions await experimental verification in vivo.
In mammals, two separate nonclonal defence systems have evolved based on collectins: one circulatory and one lung system. The human lung is an organ with a large inner surface that is continu- 
